Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells-Reference-Cited by-同舟云学术

Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells

Published:2005-07-19 Issue:3 Volume:93 Page:319-330
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Bocci G,Fioravanti A,Orlandi P,Bernardini N,Collecchi P,Del Tacca M,Danesi R

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6602720.pdf

Reference46 articles.

1. Abbruzzese JL (2002a) New applications of gemcitabine and future directions in the management of pancreatic cancer. Cancer 95: 941–945

2. Abbruzzese JL (2002b) Past and present treatment of pancreatic adenocarcinoma: chemotherapy as a standard treatment modality. Semin Oncol 29: 2–8

3. Agarwal B, Bhendwal S, Halmos B, Moss SF, Ramey WG, Holt PR (1999) Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells. Clin Cancer Res 5: 2223–2229

4. Barton-Burke M (1999) Gemcitabine: a pharmacologic and clinical overview. Cancer Nurs 22: 176–183

5. Bergman AM, Ruiz vHV, Veerman G, Kuiper CM, Peters GJ (1996) Synergistic interaction between cisplatin and gemcitabine in vitro. Clin Cancer Res 2: 521–530

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory effects of statins on Akt signaling for prevention of cancers;Cellular Signalling;2024-08

2. The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies;Metabolites;2024-07-17

3. Repositioning of HMG-CoA Reductase Inhibitors as Adjuvants in the Modulation of Efflux Pump-Mediated Bacterial and Tumor Resistance;Antibiotics;2023-09-20

4. Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma;Cell Death & Disease;2023-07-26

5. Gemcitabine‑fucoxanthin combination in human pancreatic cancer cells;Biomedical Reports;2023-06-01